Literature DB >> 1712780

Pretranslational mechanisms determine the type of potassium channels expressed in the rat skeletal and cardiac muscles.

H Matsubara1, E R Liman, P Hess, G Koren.   

Abstract

We have cloned a cDNA (RMK2) coding for a Shaker type delayed rectifier K+ channel from a rat skeletal muscle cDNA library. The clone encodes a putative protein of 602 amino acids, identical with a rat brain K+ channel Kv1 (Swanson, R., Marshall, R., Smith, J. S., Williams, J. B., Boyle, M. B., Folander, K., Luneau, C. J., Antanavage, J., Oliva, C., Burhow, S. A., Bennet, C., Stein, R. B., and Kaczmarek, L. K. (1990) Neuron 4, 929-939). Northern blot analysis showed that RMK2 is expressed in skeletal and cardiac muscle. RNase protection analysis showed that the 3'-noncoding regions of the brain, cardiac, and skeletal muscle RMK2 transcripts are identical. Cloning of the gene confirmed that the protein is encoded by a single exon (Swanson et al. (1990) Neuron 4, 929-939). We expressed RMK2 in Xenopus oocytes and showed that it encodes noninactivating delayed rectifier K+ channels, resistant to block by external tetraethylammonium, with a small unitary conductance of 8.0 picosiemens. Coinjection of RMK2 and RCK1 (RMK1) (Baumann, A., Grupe, A., Ackermann, A., and Pongs, O. (1988) EMBO J. 7, 2457-2463; Koren, G., Liman, E. R., Logothetis, D. E., Nadal-Ginard, B., and Hess, P. (1990) Neuron 4, 39-51) into Xenopus oocytes resulted in the expression of currents that have tetraethylammonium inhibition curves that differ from the linear combination of inhibition curves of the two types expressed individually. Thus, RMK2 and RCK1 (RMK1) can form heteromultimers. RNA blot hybridization analysis revealed that the RMK2 transcript is developmentally regulated in a different manner in the rat skeletal muscle, ventricle, and atrium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Putative K(+) channel inSchizosaccharomyces pombe is regulated by H(+), K (+) and cAMP at transcriptional level.

Authors:  O Golubnitchaya-Labudová; V Vacata; M Höfer
Journal:  Amino Acids       Date:  1996-12       Impact factor: 3.520

2.  Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy.

Authors:  H Matsubara; J Suzuki; M Inada
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

3.  Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.

Authors:  D J Mays; J M Foose; L H Philipson; M M Tamkun
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Truncated K+ channel DNA sequences specifically suppress lymphocyte K+ channel gene expression.

Authors:  L Tu; V Santarelli; C Deutsch
Journal:  Biophys J       Date:  1995-01       Impact factor: 4.033

5.  cAMP responsive element-mediated regulation of the gene transcription of the alpha 1B adrenergic receptor by thyrotropin.

Authors:  M Kanasaki; H Matsubara; S Murasawa; H Masaki; Y Nio; M Inada
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

6.  Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel.

Authors:  B London; A Jeron; J Zhou; P Buckett; X Han; G F Mitchell; G Koren
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity.

Authors:  Nicholas Ellinwood; Dobromir Dobrev; Stefano Morotti; Eleonora Grandi
Journal:  Chaos       Date:  2017-09       Impact factor: 3.642

Review 8.  Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds.

Authors:  Rocio K Finol-Urdaneta; Aleksandra Belovanovic; Milica Micic-Vicovac; Gemma K Kinsella; Jeffrey R McArthur; Ahmed Al-Sabi
Journal:  Mar Drugs       Date:  2020-03-20       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.